Who is sponsoring NCT03849781?

NCT03849781 is sponsored by Helse Stavanger HF.

What drugs are being tested in NCT03849781?

Interventions in NCT03849781: NeoBeat with a visible display.

What condition does NCT03849781 study?

NCT03849781 studies Newborn Resuscitation, Heart Rate Monitoring.

Is NCT03849781 still recruiting?

NCT03849781 is currently status unknown. Last updated 15 May 2019.

Last reviewed 2019-05-15 · How we verify

NCT03849781

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The NeoBeat Efficacy Study for Newborns

Status unknown NA Last updated 15 May 2019

What this trial tests

NA trial testing NeoBeat with a visible display in Newborn Resuscitation in 500 participants. Status unknown.

Timeline

8 March 2019

Primary endpoint
1 July 2022

1 July 2022

Quick facts

Lead sponsor	Helse Stavanger HF
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	500
Start date	8 March 2019
Primary completion	1 July 2022
Estimated completion	1 July 2022
Sites	1 location across Norway

Drugs / interventions tested

NeoBeat with a visible display

Conditions studied

Newborn Resuscitation — all drugs for Newborn Resuscitation →
Heart Rate Monitoring — all drugs for Heart Rate Monitoring →

Sponsor

Helse Stavanger HF — full company profile →

Who can join

Under 60 Minutes, any sex, with Newborn Resuscitation or Heart Rate Monitoring. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In a multicenter randomized controlled trial the investigators will evaluate the efficacy of the novel heart rate meter NeoBeat on ventilation performance and short-term outcomes compared to standard care in newborns in need of positive pressure ventilation to initiate spontaneous breathing after birth.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Comparison of Heart Rate Feedback from Dry-Electrode ECG, 3-Lead ECG, and Pulse Oximetry during Newborn Resuscitation.
Rettedal S, Eilevstjønn J, Kibsgaard A, Kvaløy JT, et al · · 2021 · cited 19× · PMID 34943288 · DOI 10.3390/children8121092
Prevalence of bradycardia in 4876 newborns in the first minute after birth and association with positive pressure ventilation: a population-based cross-sectional study.
Rettedal S, Kibsgaard A, Kvaløy JT, Eilevstjønn J, et al · · 2024 · cited 7× · PMID 37940377 · DOI 10.1136/archdischild-2023-325878
Impact of immediate and continuous heart rate feedback by dry electrode ECG on time to initiation of ventilation after birth: protocol for a randomised controlled trial.
Rettedal S, Kibsgaard A, Eilevstjønn J, Kvaløy JT, et al · · 2022 · cited 7× · PMID 36691167 · DOI 10.1136/bmjopen-2022-061839
Impact of Heart Rate Monitoring Using Dry-Electrode ECG Immediately After Birth on Time to Start Ventilation: A Randomized Trial.
Rettedal S, Kibsgaard A, Buskov F, Eilevstjønn J, et al · · 2025 · PMID 40868533 · DOI 10.3390/children12081082

Verify or expand the search:

Other Helse Stavanger HF trials

Trials by the same sponsor.

NCT06983002 — Bridging Affect Consciousness, Mentalization and Trauma- Exploring an Integrative Treatment Approach for Personality Dis · NA · not yet recruiting
NCT06774261 — Phenserine on the Alzheimer's Treatment Horizon, Study 1 · Phase 1 · not yet recruiting
NCT06362707 — Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD) · Phase 2 · recruiting
NCT06211907 — Small Macular Holes Treated With Air · NA · recruiting
NCT06150274 — Comparison of Wire Assisted Percutaneous Balloon Mitral Valvulotomy With Standard Inoue Balloon Valvulotomy · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03849781 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Helse Stavanger HF
Last refreshed: 15 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03849781.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing